These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

927 related articles for article (PubMed ID: 32249102)

  • 21. On the frontline against COVID-19: Community pharmacists' contribution during a public health crisis.
    Cadogan CA; Hughes CM
    Res Social Adm Pharm; 2021 Jan; 17(1):2032-2035. PubMed ID: 32245691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FIP's response to the COVID-19 pandemic: Global pharmacy rises to the challenge.
    Sousa Pinto G; Hung M; Okoya F; Uzman N
    Res Social Adm Pharm; 2021 Jan; 17(1):1929-1933. PubMed ID: 33317767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the COVID-19 epidemic on the provision of pharmaceutical care in community pharmacies.
    Koster ES; Philbert D; Bouvy ML
    Res Social Adm Pharm; 2021 Jan; 17(1):2002-2004. PubMed ID: 33317768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Community pharmacists and communication in the time of COVID-19: Applying the health belief model.
    Carico RR; Sheppard J; Thomas CB
    Res Social Adm Pharm; 2021 Jan; 17(1):1984-1987. PubMed ID: 32247680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community pharmacists' roles during the closure stage of the COVID-19 pandemic in Newfoundland and Labrador, Canada: a qualitative case study.
    Farooq S; Donnan JR; Lukewich J; Mathews M; Lee TA
    BMJ Open; 2024 Aug; 14(8):e085338. PubMed ID: 39107026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Particularities of Pharmaceutical Care in Improving Public Health Service during the COVID-19 Pandemic.
    Ghibu S; Juncan AM; Rus LL; Frum A; Dobrea CM; Chiş AA; Gligor FG; Morgovan C
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crisis management in community pharmacies during a pandemic.
    Latonen S; Neuvonen E; Juppo AM; Seeck H; Airaksinen M
    Res Social Adm Pharm; 2024 Sep; 20(9):940-948. PubMed ID: 38945767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coping with the burden of the COVID-19 pandemic: a cross-sectional study of community pharmacists from Serbia.
    Jovičić-Bata J; Pavlović N; Milošević N; Gavarić N; Goločorbin-Kon S; Todorović N; Lalić-Popović M
    BMC Health Serv Res; 2021 Apr; 21(1):304. PubMed ID: 33823866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacy participation and claim characteristics in the Wisconsin Medicaid Pharmaceutical Care Program from 1996 to 2007.
    Look KA; Mott DA; Leedham RK; Kreling DH; Hermansen-Kobulnicky CJ
    J Manag Care Pharm; 2012 Mar; 18(2):116-28. PubMed ID: 22380471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What role could community pharmacists in Malaysia play in diabetes self-management education and support? The views of individuals with type 2 diabetes.
    Lee EL; Wong PS; Tan MY; Sheridan J
    Int J Pharm Pract; 2018 Apr; 26(2):138-147. PubMed ID: 28574154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Community pharmacists' needs, education, and readiness in facing COVID-19: Actions & recommendations in Egypt.
    Kassem AB; Ghoneim AI; Nounou MI; El-Bassiouny NA
    Int J Clin Pract; 2021 Nov; 75(11):e14762. PubMed ID: 34472166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resilience in the time of pandemic: The experience of community pharmacists during COVID-19.
    Austin Z; Gregory P
    Res Social Adm Pharm; 2021 Jan; 17(1):1867-1875. PubMed ID: 32499160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fighting against COVID-19: Innovative strategies for clinical pharmacists.
    Li H; Zheng S; Liu F; Liu W; Zhao R
    Res Social Adm Pharm; 2021 Jan; 17(1):1813-1818. PubMed ID: 32278766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging pharmacy services; Recommendations for emergency care of COVID-19 pandemic in low and middle-income countries.
    Hamid H; Masood RA; Khalid W; Saqlain M; Tariq H; Munir MU
    Pak J Pharm Sci; 2020 Jul; 33(4):1735-1738. PubMed ID: 33583810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multilevel Engagements of Pharmacists During the COVID-19 Pandemic: The Way Forward.
    Mallhi TH; Liaqat A; Abid A; Khan YH; Alotaibi NH; Alzarea AI; Tanveer N; Khan TM
    Front Public Health; 2020; 8():561924. PubMed ID: 33364224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized controlled study of practice facilitation to improve the provision of medication management services in Alberta community pharmacies.
    Houle SK; Charrois TL; Faruquee CF; Tsuyuki RT; Rosenthal MM
    Res Social Adm Pharm; 2017; 13(2):339-348. PubMed ID: 27017157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation of comprehensive medication management at supermarket pharmacies in a pharmacy network.
    Doong K; Berenbrok LA; Coley KC; Carroll JC; Richardson R; Antinopoulos BC; Patel A; McGivney MS
    J Am Pharm Assoc (2003); 2019; 59(4S):S25-S31. PubMed ID: 31080149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of community pharmacists in providing clinical medication reviews.
    Laaksonen R; Duggan C; Bates I
    Ann Pharmacother; 2010; 44(7-8):1181-90. PubMed ID: 20571102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Irrational pharmacy practice and inadequate health care services in Bangladesh: a lesson learned from COVID-19 pandemic.
    Jakaria M; Azam S; Siddiqui SA; Hoq MI; Islam MS
    J Basic Clin Physiol Pharmacol; 2021 Apr; 32(3):129-130. PubMed ID: 33915611
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.